-Impact of the change in mRS from pre-stroke to 3-months post-stroke (∆mRS) on 1-year and 5-year mortality, institutionalization, and death/institutionalization for 3-month survivors of ischaemic stroke with pre-morbid mRS of 2 -controlling for age, sex, and National Institutes of Health Stroke Scale (NIHSS) score at acute presentation. The institutionalization analyses exclude pre-morbidly institutionalized patients. Table VI -Impact of the change in mRS from pre-stroke to 3-months post-stroke (∆mRS) on 5-year health and social care costs in 3-month ischaemic stroke survivors with pre-morbid mRS of 2-4, excluding pre-morbidly institutionalized patients (n=34) and censored patients (n=29, 2 of whom were already institutionalized). 55,619 (11,683-99,555) 0.013 20,928 (-20,911-62,766) 0.33 N/A 3 54,762 (-28,758-138,281) 0.20 73,492 (-17,802-164,786) -8,874 (-19,857-2,109) 0.11 -9,473 (-22,432-3,485) 0. 15 -7,624 (-24,407-9,159) 0. 37 -35,849 (-89,902-18,204) 0.19 The graphs show the proportion of 3-month survivors, also alive at (A) 1-year, who were institutionalized by 1-year post-stroke, and (B) also alive at 5-years, who were institutionalized by 5-years post-stroke. Institutionalization was defined as admission to a nursing or residential care home. The P-values from chi-squared tests for differences between mRS grades are indicated. Bars represent 95% confidence intervals.
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Figure II. Kaplan-Meier survival curves after index stroke for 3-month survivors with premorbid mRS of 2-4, stratified by the change in mRS between pre-stroke and 3-months post-stroke (∆mRS), for (A) 5-year mortality, (B) 5-year institutionalization, and (C) 5-year mortality/institutionalization. Since only 3-month survivors with a pre-morbid mRS of 2 could have a ∆mRS of 3, we combined them with patients with a pre-morbid mRS of 3 who had a ∆mRS of 2 ("∆mRS≥2"). P-values from log-rank test for each group are shown.
